Establishes that the council on human blood and transfusion services shall review all current medical research and guidance regarding the donation of blood by patients with a history of Lyme or tick-borne illnesses.
Impact
If enacted, the bill is expected to positively influence the safety of blood donation practices by integrating updated research findings into public health protocols. Given the growing concerns around tick-borne diseases, the implications of this bill may lead to heightened awareness and preventive measures in the medical community. Thus, it seeks to mitigate risks associated with blood donations from patients who have experienced these illnesses, potentially affecting policies at blood banks and hospitals throughout the state.
Summary
Bill A07955 aims to amend public health law in New York concerning the donation of blood by individuals with a history of Lyme or tick-borne illnesses. The bill establishes a task for the council on human blood and transfusion services to review current medical research and guidance around this topic. The objective is to ensure that the guidelines for blood donation are informed by the latest scientific insights regarding the health risks associated with these specific diseases. The council is required to present its recommendations within ninety days, which may include the establishment of moratoriums on blood collections from at-risk individuals.
Contention
Notable points of contention surrounding Bill A07955 may arise from the balance between ensuring public health safety and possibly restricting blood donations from those with tick-borne illness histories. There could be debates on whether the bill may lead to over-cautiousness in blood donation policies that might limit the blood supply. Furthermore, stakeholders may express differing opinions regarding the adequacy of existing research and whether it justifies stringent restrictions on donations from affected individuals.
Same As
Establishes that the council on human blood and transfusion services shall review all current medical research and guidance regarding the donation of blood by patients with a history of Lyme or tick-borne illnesses.
Establishes that the council on human blood and transfusion services shall review all current medical research and guidance regarding the donation of blood by patients with a history of Lyme or tick-borne illnesses.
Requires health insurers to provide coverage for long term medical care for Lyme disease and other tick borne related pathogens; provides for taxpayer gifts for tick borne illness research, detection and education; establishes the tick borne illness research, detection and education fund.
Urging the Congress of the United States to establish policies that would provide greater access to blood transfusions for hospice patients with blood cancer.
Providing for patient access to diagnostics and treatments for Lyme disease and related tick-borne illnesses; and requiring health care policies to provide certain coverage.
Requiring health care facilities to provide autologous blood transfusions and direct allogeneic blood transfusions to individuals under certain circumstances.
Providing for patient election for donation and use of autologous blood; providing for disclosure of vaccination status in blood transfusions and requiring informed consent; and imposing duties on the Department of Health.